Atrioventricular Nodal Reentrant Tachycardia (AVNRT): Symptoms, Diagnosis & Treatment

AVNRT is a re-entrant arrhythmia whose critical isthmus sits in atrioventricular nodal tissue and contiguous slow-conduction perinodal atrial bundles. Functional dual pathways (typically a slow-conducting but fast-recovering route versus a fast-conducting AV nodal route) allow a premature atrial or junctional beat to block antegradely in one limb while recovering the other, setting up continuous micro-reentry that conducts to the ventricles 1:1 through the His–Purkinje system—explaining the sudden patient experience of an “off–on” racing pulse.

Because ventricular activation still traverses the normal His bundle, QRS duration usually stays narrow unless bundle-branch block or aberrancy appears. The arrhythmia is grouped with other paroxysmal SVT mechanisms; distinguishing AVNRT from atrioventricular reentrant tachycardia using an accessory pathway, or from atrial flutter with 2:1 conduction, changes drug choices and ablation targets, so epistemic humility at the bedside serves patients better than premature diagnostic closure.

Electrophysiologists label circuits by the direction of slow versus fast pathway use during tachycardia. The table condenses patterns nurses hear verbalised after invasive studies; surface ECG alone may not separate subtypes reliably.

↔On a small screen, swipe or scroll sideways to see the full table.

Definitive mapping belongs to invasive electrophysiology; nursing documentation of rhythm strips during interventions accelerates later correlation.

Patients often describe abrupt awareness of rapid heartbeat, throat pulsation, anxiety surge, or presyncope. Episodes may interrupt exercise, emotional stress, caffeine excess, heavy meals, or the luteal phase; some wake from sleep with tachycardia. Symptoms typically switch off suddenly after vagal manoeuvres or acute therapy—contrast with sinus tachycardia that ramps gradually.

Frequent descriptors

• Paroxysmal palpitations with an anxious affect yet clear sensorium between episodes.
• Polyuria after long runs from atrial natriuretic peptide release—often surprises clinicians evaluating suspected dehydration.
• Transient fainting when rates exceed cerebral autoregulation or vasovagal co-triggers appear.

Atypical presentations to flag

• Exertional syncope or chest tightness mimicking acute coronary syndrome—correlate with enzymes and imaging pathways locally.
• “Fluttering” that is irregularly irregular—suggests atrial fibrillation more than AVNRT; still capture rhythm.

Younger and middle-aged adults, particularly those assigned female at birth in epidemiological series, present frequently, yet AVNRT also appears in older adults when conduction disease distorts ECG interpretation. Structural heart disease is uncommon in isolation but does not exclude AVNRT when dyspnoea prompts hospitalisation—always integrate echocardiographic findings.

Modifiable precipitants

• Excess caffeine, nicotine, illicit stimulants, sympathomimetic cold remedies.
• Hyperthyroidism or undertreated anaemia lowering the arrhythmia threshold.
• Dehydration or peri-infection catecholamine surges in hospitalised patients.

Non-modifiable substrate

• Inherited clustering of SVT—history-taking should query family members with ablation or unexplained syncope.
• Postsurgical atriotomy scarring rarely masquerades as AVNRT—EP clarification required.

Clinical assessment

Quantify episode frequency, duration, abortive manoeuvres, prior ED visits, and medication responses. Review thyroid function trends, electrolytes, haemoglobin, and toxicology when age or behaviour suggests stimulant use. Ask specifically about aborted sudden death in relatives to heighten awareness of channelopathies or accessory pathways.

Laboratory investigations

Baseline testing mirrors other palpitation work-ups: thyroid-stimulating hormone, renal function before contrast or renally cleared drugs, magnesium and potassium if diarrhoea/diuretics coexist, and troponin sampling when chest pain is atypical or risk factors for coronary disease dominate the differential.

Imaging and rhythm correlation

A 12-lead during tachycardia is the highest-yield single test—copy it to the chart and hand-off package. When events are sporadic, deploy Holter monitors, event recorders, or implantable loop recorders per cardiology. Echocardiography screens for structural drivers (valve disease, hypertrophy) influencing drug safety; functional or exercise stress imaging occasionally follows if ischaemia concerns persist after rhythm control.

Invasive electrophysiology

Catheter stimulation confirms dual-pathway physiology, differentiates AVNRT from orthodromic reciprocating tachycardia, and guides slow-pathway modification. Nurses organise vascular access sites, anticoagulation bridges, post-ablation rhythm surveillance, and groin haemostasis education.

↔On a small screen, swipe or scroll sideways to see the full table.

Acute therapy (perfusion intact)

Guide patients through standardised Valsalva (often with passive leg raise afterwards) while someone watches telemetry. If unsuccessful, IV adenosine remains the classic pharmacologic terminator for narrow-complex regular SVT when no contraindication exists—give through proximal IV with rapid flush per protocol and warn about transient dyspnoea or asystole sensation.

Second-line IV options in many algorithms include diltiazem or verapamil versus beta-blockers such as metoprolol or esmolol—selection balances bronchospasm risk, hypotension, and concomitant reduced ejection fraction considerations already tabled by cardiology.

Refractory or recurrent cases

IV amiodarone appears in selected escalation pathways when AV-node blockers fail or are undesirable, but require vigilance for hypotension, phlebitis, and interactions. Class Ic agents (for example flecainide) surface chiefly as oral “pill-in-the-pocket” strategies in structurally normal hearts with specialist oversight and QT surveillance.

Definitive care

Catheter ablation of the slow pathway offers high cure rates for symptomatic AVNRT; discuss AV-block risk, venous access complications, and radiation minimisation strategies during consent witnessed by nursing colleagues. Post-ablation monitoring focuses on PR-interval trends and inadvertent heart-block symptoms.

• Monitoring cadence: continuous telemetry during active termination attempts; repeat vital signs at protocolled intervals for four cycles after conversion or cardioversion.
• Medication safety: screen methylxanthine excess, dipyridamole use, and severe bronchospasm before adenosine; document rhythm strips for each dose.
• Failure criteria: two appropriately delivered adenosine doses without termination should trigger clinician reassessment rather than unsupervised repetition—consider alternate diagnosis or antiarrhythmic escalation per protocol.
• Referral triggers: disabling symptoms, employment affecting public safety, aborted syncope, or reluctance toward lifelong meds warrant EP clinic prioritisation.
• Documentation bundle: symptom timeline, drug doses with flush volumes, vagal technique specifics, consents for cardioversion, and patient education on driving rules.

Clinical decision flow (shift-ready)

1. Stabilise first: airway, breathing, circulation, focused rhythm strip, large-bore IV, oxygen only if hypoxic.
2. Stable narrow-complex regular tachycardia? vagal → adenosine → nodal blocker per order set; capture 12-lead before and after.
3. Wide or uncertain QRS? treat as ventricular until electrophysiology/cardiology refutes; avoid nodal-only blockade.
4. Converted? observe for relapse, reconcile home meds, arrange ambulatory follow-up within days if first presentation.

Bedside monitoring checklist

• Continuous rhythm with alarm limits sensitised to pauses post-adenosine.
• Blood pressure trending; orthostatic checks if light-headed.
• Respiratory rate and work of breathing after any sedative or beta-blocker bolus.
• Point-of-care glucose when confusion or diabetes coexists.

• Haemodynamic collapse from prolonged rapid rates or misclassified wide-complex tachycardia.
• Fall-related injury during syncope—especially bathroom mobilisation after diuresis.
• Iatrogenic high-grade AV block complicating ablation—watch for slow junctional escape rhythms post-procedure.
• Drug-induced hypotension when multiple AV nodal agents stack without reassessment.

For clinicians, prevention translates into trigger reduction (moderating stimulants, treating hyperthyroidism, optimising sleep apnoea therapy where relevant) plus scheduled rhythm-control medication titration or elective ablation before occupation-critical recurrence. Teach patients to avoid unsupervised pseudoephedrine stacking and to bring pill bottles to every visit so pharmacists review digoxin or other rate-slowing combinations deliberately.

Isolated AVNRT in structurally normal hearts typically confers favourable long-term survival once symptoms are controlled; ablation offers durable freedom from episodes for many patients. Prognosis shifts when coexisting coronary disease or systolic dysfunction amplifies the impact of rate surges—those cohorts merit tighter cardiology follow-up and optimised guideline-directed heart failure therapy when that comorbidity exists.

Communication

Use plain language to rehearse what adenosine will feel like, why flushing matters, and when to shout for help—anticipatory guidance reduces panic-induced hyperventilation that obscures post-conversion assessment.

Equity and access

Home-monitoring smartphones help affluent patients capture rhythms; proactively arrange hospital telemetry or community monitors for those without devices so diagnostics do not skew by socioeconomic status.

Medication teaching

Pair flecainide pill-in-the-pocket counselling—when prescribed—with written thresholds for ED return; emphasise checking pulse regularity before swallowing PRN antiarrhythmics when instructed.

Call the resuscitation team per local policy while preparing defibrillator pads if wide-complex tachycardia with instability emerges—do not delay for pharmacy batch preparation.

These NCLEX-style clinical judgment practice items focus on the nursing priorities for this condition — recognise cues, escalate red flags, take safe action and evaluate outcomes (NCSBN Clinical Judgment Measurement Model) — through Priority FIRST, SATA, deterioration trends, multi-patient triage, ordered response, matrix matching and a compact cloze on the topic of AVNRT, vagal manoeuvres, IV adenosine technique and the slow-pathway catheter-ablation pathway.